HLA-DRA


Summary: HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in HLA-DRA


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC TAS GO:0000139 Golgi membrane
CC IDA GO:0005764 lysosome
CC IDA GO:0005765 lysosomal membrane
CC TAS GO:0005765 lysosomal membrane
CC IDA GO:0005886 plasma membrane
CC TAS GO:0005886 plasma membrane
Showing 1 to 6 of 31 rows rows per page

Gene expression in normal tissue: HLA-DRA

Gene-model tissue-cancer distribution: Bubble Plot

SKItissue: SKI cancer: SKIN model num: 0SKINtissue: SKIN cancer: Melanoma (MEL) model num: 3

Gene-drug pathway distribution

undefined3

Pathways in HLA-DRA


Loading, please wait...
Database
Pathway ID
Pathway Des.
biocarta cskpathway activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor
biocarta ctla4pathway the co-stimulatory signal during t-cell activation
biocarta il4pathway il 4 signaling pathway
biocarta mef2dpathway role of mef2d in t-cell apoptosis
biocarta mhcpathway antigen processing and presentation
biocarta tcrapathway lck and fyn tyrosine kinases in initiation of tcr activation
Showing 1 to 6 of 51 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD955 Nivolumab 1
iGMDRD978 Pembrolizumab 1
iGMDRD824 Atezolizumab 1
Showing 1 to 3 of 3 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in HLA-DRA

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​